Analyst consensus rating
Pulse Biosciences Analyst Rating: Strong Buy
PLSE is rated Strong Buy by 4 analysts with a $45.25 target. As of 2026-09-01.
Direct answer
Pulse Biosciences's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $45.25.
Forecast evidence checked September 1, 2026.
Get free Pulse Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $52.09
- Average price target
- $45.25
- High price target
- $58.00
- Low price target
- $35.00
- Low target gap
- -32.8%
- Target upside
- -13.1%
- High target gap
- +11.3%
- Target range width
- 44.2%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pulse Biosciences?
Pulse Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $45.25.
How far are Pulse Biosciences's low and high targets from the recorded price?
The low target implies -32.8%, while the high target implies +11.3%.
How many analysts are included in Pulse Biosciences's consensus?
The verified consensus includes 4 analysts.
How is Pulse Biosciences's target upside or downside calculated?
The average target of $45.25 is divided by the recorded price of $52.09, then one is subtracted to produce -13.1%. This does not guarantee a future return.
When was Pulse Biosciences's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.